bms204352 has been researched along with muraglitazar in 1 studies
| Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) |
|---|---|---|---|---|---|
| 49 | 1 | 12 | 85 | 10 | 25 |
| Protein | Taxonomy | bms204352 (IC50) | muraglitazar (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.1867 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L; Zhang, D; Zhao, W; Zhu, M | 1 |
1 other study(ies) available for bms204352 and muraglitazar
| Article | Year |
|---|---|
Rapid and sensitive characterization of the metabolite formation enzyme kinetics of radiolabeled drugs using stop-flow liquid radiochromatography.
Topics: Buspirone; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Glucuronides; Glycine; Humans; Indoles; Microsomes, Liver; Oxazoles; Reproducibility of Results; Scintillation Counting | 2008 |